JP2012193207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012193207A5 JP2012193207A5 JP2012157469A JP2012157469A JP2012193207A5 JP 2012193207 A5 JP2012193207 A5 JP 2012193207A5 JP 2012157469 A JP2012157469 A JP 2012157469A JP 2012157469 A JP2012157469 A JP 2012157469A JP 2012193207 A5 JP2012193207 A5 JP 2012193207A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- pulmonary disease
- lung
- interferon gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000019693 Lung disease Diseases 0.000 claims 19
- 102000008070 Interferon-gamma Human genes 0.000 claims 12
- 108010074328 Interferon-gamma Proteins 0.000 claims 12
- 229960003130 interferon gamma Drugs 0.000 claims 12
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 5
- 229960002170 azathioprine Drugs 0.000 claims 5
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 claims 5
- 239000003246 corticosteroid Substances 0.000 claims 5
- 229960001334 corticosteroids Drugs 0.000 claims 5
- 229960004397 cyclophosphamide Drugs 0.000 claims 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims 4
- 239000003018 immunosuppressive agent Substances 0.000 claims 4
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 3
- 208000011623 Obstructive Lung disease Diseases 0.000 claims 3
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 230000001506 immunosuppresive effect Effects 0.000 claims 3
- 229940124589 immunosuppressive drug Drugs 0.000 claims 3
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 3
- 210000004072 lung Anatomy 0.000 claims 3
- 230000001668 ameliorated effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229960003444 immunosuppressant agent Drugs 0.000 claims 1
- 230000001861 immunosuppressant effect Effects 0.000 claims 1
- 238000013123 lung function test Methods 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 238000009613 pulmonary function test Methods 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
Claims (28)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012157469A JP2012193207A (en) | 2012-07-13 | 2012-07-13 | Method for treating pulmonary disease with interferon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012157469A JP2012193207A (en) | 2012-07-13 | 2012-07-13 | Method for treating pulmonary disease with interferon |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008532198A Division JP5175198B2 (en) | 2005-09-20 | 2005-09-20 | Method for treating pulmonary disease using interferon |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014258344A Division JP2015057446A (en) | 2014-12-22 | 2014-12-22 | Method for treating pulmonary disease with interferon |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012193207A JP2012193207A (en) | 2012-10-11 |
JP2012193207A5 true JP2012193207A5 (en) | 2013-01-10 |
Family
ID=47085448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012157469A Withdrawn JP2012193207A (en) | 2012-07-13 | 2012-07-13 | Method for treating pulmonary disease with interferon |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2012193207A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116251174B (en) * | 2022-12-23 | 2023-09-29 | 北京三元基因药业股份有限公司 | Pharmaceutical assembly comprising an inhalation solution of human interferon alpha 1b |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60026618T2 (en) * | 1999-12-30 | 2007-01-18 | Intermune, Inc., Brisbane | GAMMA-IFN LIQUID DROPSAEROSOL AND METHOD |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
AUPR381601A0 (en) * | 2001-03-19 | 2001-04-12 | Monash University | Method of treating respiratory conditions |
-
2012
- 2012-07-13 JP JP2012157469A patent/JP2012193207A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130835T1 (en) | Pharmaceutical solution formulations for pressurised metered dose inhalers | |
JP2011520911A5 (en) | ||
NZ600790A (en) | Combination therapy for copd | |
JP2010132695A5 (en) | ||
JP2011528355A5 (en) | ||
JP2007520508A5 (en) | ||
JP2013542940A5 (en) | ||
JP2011144201A5 (en) | ||
KR20110122671A (en) | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
RU2010108640A (en) | NEW COMBINATION OF THERAPEUTIC AGENTS | |
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
JP2016510012A5 (en) | ||
MD4369B1 (en) | Use of glycopyrrolate for treating tachycardia, unit dose, delivery device, method of treatment and prophylaxis of tachycardia | |
JP2013507429A5 (en) | ||
WO2012040228A3 (en) | Aerosol composition for administering drugs | |
JP2015519356A5 (en) | ||
JP2009544690A5 (en) | ||
PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
HRP20231621T1 (en) | Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection | |
EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
CN103476412B (en) | Aclidinium for improving respiratory disease patient sleeps' mass | |
JP2014520874A5 (en) | ||
JP2012193207A5 (en) | ||
JP2011500731A5 (en) | ||
JP2016502992A5 (en) |